Journals / Türk Kardiyoloji Derneği Arşivi / 2005 / Cilt: 33 - Sayı: 8

Intensive antithrombotic treatment including tirofiban for intracoronary thrombosis in a patient with non-ST segment elevation acute myocardial infarction

ST yükselmesiz akut miyokard infarktüsü geçiren bir hastada intrakoroner trombüs için tirofiban içeren yoğun antitrombotik tedavi

Pages
476–479
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The patient was asymptomatic during a follow-up of three months.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A 50-year-old male patient who presented with chest pain was hospitalized with a diagnosis of non-Q-wave myocardial infarction.
📊
Key Findings & Data:Treatment with aspirin, clopidogrel, nitrates, beta-blocker, and heparin did not relive pain.
💡
Conclusion & Impact:The patient was asymptomatic during a follow-up of three months.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

A 50-year-old male patient who presented with chest pain was hospitalized with a diagnosis of non-Q-wave myocardial infarction. Treatment with aspirin, clopidogrel, nitrates, beta-blocker, and heparin did not relive pain. Coronary angiography showed slow flow in the left anterior descending coronary artery and massive thrombotic occlusion in the septal artery. Tirofiban administration resulted in relief of chest pain. Control coronary angiography performed at 72 hours showed complete disappearance of the intracoronary thrombus, but slow flow in the left anterior descending coronary artery persisted. The patient was asymptomatic during a follow-up of three months.

Özet

Göğüs ağrısıyla başvuran 50 yaşındaki erkek hasta, yapılan incelemeler sonucunda Q dalgasız miyokard infarktüsü tanısıyla yatırıldı. Hastanın ağrısının aspirin, klopidogrel, nitrat, beta-bloker ve heparin tedavisiyle geçmemesi üzerine yapılan koroner anjiyografide, sol ön inen arterde yavaş akım ve septal arterde trombüsle uyumlu lezyon saptandı. Tirofiban tedavisine başlanan hastada göğüs ağrısı tekrarlamadı ve 72. saatte yapılan koroner anjiyografide septal arter içindeki trombüsün erimiş olduğu görüldü; ancak sol ön inen arterde yavaş akım devam ediyordu. İzlenmekte olduğu üç aylık sürede hastanın asemptomatik olduğu görüldü.

🔖

Cite This Article

YİĞİT, F., MÜDERRİSOĞLU, H., BATUR, M. K., TEKİN, G. (2022). Intensive antithrombotic treatment including tirofiban for intracoronary thrombosis in a patient with non-ST segment elevation acute myocardial infarction. Türk Kardiyoloji Derneği Arşivi, Cilt: 33 - Sayı: 8, 476–479. https://ajindex.com/articles/633793

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Zhao XQ, Theroux P, Snapinn SM, Sax FL. Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms). PRISM-PLUS Investigators. Circulation 1999;100:1609-15
  2. Tambe AA, Demany MA, Zimmerman HA, Mascarenhas E. Angina pectoris and slow flow velocity of dye in coronary arteries-a new angiographic finding. Am Heart J 1972;84:66-71
  3. Van Belle E, Lablanche JM, Bauters C, Renaud N, McFadden EP, Bertrand ME. Coronary angioscopic findings in the infarct-related vessel within 1 month of acute myocardial infarction: natural history and the effect of thrombolysis. Circulation 1998;97:26-33
  4. Boston DR, Malouf A, Barry WH. Management of intracoronary thrombosis complicating percutaneous transluminal coronary angioplasty. Clin Cardiol 1996; 19:536-42
  5. Lincoff AM, Popma JJ, Ellis SG, Hacker JA, Topol EJ. Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile. J Am Coll Cardiol 1992;19:926-35
  6. Lefkovits J, Plow EF, Topol EJ. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med 1995;332:1553-9
  7. Kong DF, Califf RM, Miller DP, Moliterno DJ, White HD, Harrington RA, et al. Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease. Circulation 1998; 98:2829-35
  8. Muhlestein JB, Karagounis LA, Treehan S, Anderson JL. “Rescue” utilization of abciximab for the dissolution of coronary thrombus developing as a complication of coronary angioplasty. J Am Coll Cardiol 1997;30:1729-34
  9. Haase KK, Mahrholdt H, Schroder S, Baumbach A, Oberhoff M, Herdeg C, et al. Frequency and efficacy of glycoprotein IIb/IIIa therapy for treatment of threatened or acute vessel closure in 1332 patients undergoing percutaneous transluminal coronary angioplasty. Am Heart J 1999;137:234-40
  10. Rechavia E, Wurzel M. Platelet glycoprotein IIb/IIIa receptor blockade in acute myocardial infarction associated with thrombotic occlusion of the left main coronary artery. Circulation 1998;98:1249-50
  11. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited b